PTEN and breast cancer: Toomey106 used IHC to assess the level of PTEN protein and found that 14 of 45 (31.1%) tumours samples had low (absent or weak) PTEN expression and PR‐negative tumour had higher PTEN expression than PR‐positive tumours (37.9% vs 18.8%) in BC.